antiarrhythmic drug Lignocaine Injection (lidocaine) Drug

Price	USD30.00
Packge	25Kg/Drum

Min. Order:10g
Supply Ability:100000 tons
Time:2022-03-16

Product Details

Product NameLignocaine Injection (lidocaine) Drug

Lidocain, xylocaine, or lignocaine is a common local anesthetic and class-1b antiarrhythmic drug Lignocaine Injection (lidocaine) Drug

Contact me :

Whatsapp/Signal/Telegram: 0086 198 3195 3957

Wickr: jane8886

Fax :86-027- 86657186

Email: jane@whmulei.com

Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Product Name	Lidocaine cas 137-58-6
Lidocaine Alias	2-Diethylamino-N-(2,6-dimethylphenyl) acetamide Lignocaine , cas 137-58-6
Lidocaine Density	1.0 + / - 0.1 g/cm3
Lidocaine Molecular weight	234.337
Lidocaine Molecular formula	C14H22N2O
Lidocaine Boiling point	310.7±15.0 °C at 760 mmHg
Lidocaine Melting point	66-69 ° C
Lidocaine Flash point	179.2 + / - 30.7 ° C
Lidocaine Appearance	white crystalline powder
Lidocaine Storage conditions	Sealed in a cool and dry place for storage.
Lidocaine Feature	Incompatible with strong oxidizing agents , Water is practically insoluble
Lidocaine Useful	Lidocaine used for cardiovascular system, central nervous system
Lidocaine Packing	25kg/drum or as your requirements

Lidocaine Function:

1. Lidocaine, xylocaine, or lignocaine is a common local anesthetic and class-1b antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning, and pain from skin inflammations, injected as a dental anesthetic, or as a local anesthetic for minor surgery.

2.It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic healthcare system.

3. Lidocaine is the most important class-1b antiarrhythmic drug; it is used intravenously for the treatment of ventricular arrhythmias (for acute myocardial infarction, digoxin poisoning, cardioversion, or cardiac catheterization) if amiodarone is not available or contraindicated.

4. Lidocaine should be given for this indication after defibrillation, CPR, and vasopressors have been initiated. A routine prophylactic administration is no longer recommended for acute cardiac infarction; the overall benefit of this measure is not convincing.

Company Profile Introduction

We are Mulei (Wuhan) New Material Technology Co. Ltd. We are top rank supplier for ketone raw material, phenacetin,caine products. To us, Our Customers are priority Value beyond profit. we strive for continuous improvement in our service, dedicate to the delivery of highest quality products to the world, deeply commit to meeting the needs of our customers, constantly focus on customer satisfaction. We look forward to working together with our peer and friends from all over the world to create a new glorious future.

Recommended supplier

VIP3年
CLEARSYNTH LABS LTD.
Urea API urinary system drug
$ 490.0000/1kg
2022-05-19

Wuhan Mulei New Material Technology Co. Ltd

Hubei China

Since:2016-08-03
Address: No. 10025, 2 / F, Building 1, Optical Valley Avenue, East Lake High-tech Development Zone, Wuhan

INQUIRY